http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MY-106724-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94b51d317764e2f4f1bbcb355b274c8b
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D305-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335
filingDate 1990-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b13d17543d7d2bfd7e5496af47664fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ab83a4bd5f6bcc95283664b129be305
publicationDate 1995-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MY-106724-A
titleOfInvention Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof.
abstract DERIVATIVES OF TAXOL REPRESENTED BY THE FORMULA WHEREIN R AND R'' ARE EACH H OR THE RESIDUE OF AN AMINO ACID SELECTED FROM THE GROUP CONSISTING OF ALANINE, LEUCINE, ISOLEUCINE, SALINE,PHENYLALANINE, PROLINE, IYSINE AND ARGININE OR A GROUP OF THE FORMULA WHEREIN N IS AN INTEGER OF 1 TO 3 AND R2 AND R3 ARE EACH HYDROGEN ON AN ALKYL RADICAL HAVING FROM ONE TO THREE CARBON ATOMS OR WHEREIN R2 AND R3 TOGETHER WITH THE NITROGEN ATOM TO WHICH THEY ARE ATTACHED FORM A SATURATED HETEROCYCLIC RING HAVING FOUR TO FIVE CARBON ATOMS, WITH THE PROVISO THAT AT LEAST ONE OF R AND R1 IS NOT HYDROGEN, ARE PROVIDED TOGETHER WITH PHARMACEUTICAL COMPOSITIONS OF SUCH DERIVATIVES. THE TAXOL DERIVATIVES HAVE INCREASED WATER SOLUBILITY AS COMPARED TO TAXOL, AND HAVE EXCELLENT ANTITUMOR ACTIVITY.
priorityDate 1990-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID145742
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556475
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490256
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5950
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490523
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6106
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549088
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6306
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556976
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492855
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID866

Total number of triples: 34.